Endocrinology

DDP-4 Inhibitors Increase Risk of Bullous Pemphigoid

August 05, 2020

Article

Older, white patients and those who use linagliptin are at a higher risk of bullous pemphigoid.

Moderate to Severe NPDR Leads to Greater Risk of Vision-Threatening DR

July 28, 2020

Article

Eyes with moderate to severe nonproliferative diabetic retinopathy more often develop eye worsening compared to those with a milder form of the condition.

Telescreening Programs Could Help Identify the Rates of Retinal Pathology

July 28, 2020

Article

A total of 115 of 200 examined eyes had some form of diabetic retinopathy in data presented at the ASRS 2020 virtual meeting.

Billing Codes Could be Useful in Capturing DME in Patients with NPDR

July 27, 2020

Article

In research presented at ASRS 2020, investigators found 56% of patients with PDR had a DME code, with a sensitivity of 85%.

Factors Associated with Blindness in Patients with Type 2 Diabetes

July 27, 2020

Article

The findings of the study highlight the importance of screening eye exams from index diagnosis.

What Is the Cross-Specialty Collaboration for Retina Disease?

July 26, 2020

Video

A look at how the specialty functions in telemedicine, and how it could work better with primary care physicians and endocrinologists.

How Diabetics Progress to Retina Complications

July 25, 2020

Video

A look at how primary care patients begin to present with diabetic retinopathy risk.

Study Identifies Potential Type 2 Diabetes plus Dry Eye Biomarkers

July 05, 2020

Article

New research shows patients with both conditions have greater levels of particular cytokines and metabolic proteins.

Comparing Diabetes Therapies in Patients with Low versus Increased CV Risk

June 30, 2020

Article

A systematic review and network meta-analysis is comparing 9 classes of therapies for HbA1c and risk management in patients with low versus increased cardiovascular risk.

Metabolic Syndrome Prevalence Increases Among Young Adults

June 26, 2020

Article

There is a significant increase in metabolic syndrome prevalence among young adults, while prevalence remains high for those at least 60 years old.

x